Cash

Latest balance sheet

Net assets

-£22M

-53.2% vs 2024

Employees

204

-21.8% vs 2024

Profit before tax

-£8M

+46.8% vs 2024

Profile

Company number
14443321
Status
Active
Incorporation
2022-10-26
Last accounts made up
2025-03-31
Account category
FULL
Primary SIC
86220
Hubs
UK Healthcare

Net assets

4-year trend · vs UK Healthcare median

£0£1£12023202320242025
PHARMACY PLUS HEALTH LIMITED

Accounts

4-year trend · latest 2025-03-31

Metric Trend 2023-03-142023-03-152024-03-312025-03-31
Turnover £26,207,259£23,402,882
Operating profit -£11,539,191-£4,235,303
Profit before tax -£14,282,369-£7,594,780
Net profit -£14,282,369-£7,594,780
Cash £1
Total assets less current liabilities £1-£593,762-£8,928,140
Net assets £1-£14,282,368-£21,877,148
Equity £1£1-£14,282,368-£21,877,148
Average employees 4261204
Wages £5,853,067£5,319,362

Values shown as filed in iXBRL accounts. indicates the figure was not present in the extracted filing (either not filed under that concept or absent from the period). About these numbers

Audit & accounting basis

From AI-extracted PDF accounts

Accounting basis
FRS 102
Reporting scope
Standalone (parent only)
Auditor
Forrester Boyd Robson Limited
Audit opinion
Qualified
Going concern
Affirmed

“In auditing the financial statements, we have concluded that the directors' use of the going concern basis of accounting in the preparation of the financial statements is appropriate. Based on the work we have performed, we have not identified any material uncertainties relating to events or conditions that, individually or collectively, may cast significant doubt on the Company's ability to continue as a going concern for a period of at least twelve months from when the financial statements are authorised for issue.”

Subsidiaries

Significant events

Auditor / going-concern / subsidiary information is extracted from the PDF version of the latest annual accounts and is not tagged in iXBRL. About these numbers

People

3 active · 1 resigned

Name Role Appointed Born Nationality
LEE, Daniel Mark Director 2022-10-26 May 1970 British
PASSMORE, Sarah, Dr Director 2022-10-26 Oct 1979 British
TOLLEFSON, Matthew Thomas Director 2022-10-26 Oct 1990 British
Show 1 resigned officer
Name Role Appointed Resigned
LESTNER, Jason Elliot Director 2023-03-16 2024-04-30

Ownership

Persons with significant control

Name Kind Nature of control Notified Status
Hubrx Ltd Corporate entity Shares 75–100%, Voting 75–100%, Appoints directors 2022-10-26 Active

Filing timeline

Last 15 of 15 total filings

Date Type Category Description
2026-04-10 CS01 confirmation-statement confirmation statement with no updates
2026-03-31 AA accounts accounts with accounts type full
2025-03-31 AA accounts accounts with accounts type total exemption full
2025-03-28 CS01 confirmation-statement confirmation statement with no updates
2024-12-18 MR05 mortgage mortgage charge part both with charge number
2024-12-10 AA01 accounts change account reference date company previous extended
2024-12-08 CS01 confirmation-statement confirmation statement with no updates
2024-05-08 TM01 officers termination director company with name termination date
2024-04-29 AA accounts accounts with accounts type dormant
2024-03-01 AA01 accounts change account reference date company previous shortened
2023-11-28 CS01 confirmation-statement confirmation statement with no updates
2023-03-31 AP01 officers appoint person director company with name date
2023-03-29 MR01 mortgage mortgage create with deed with charge number charge creation date
2023-03-21 MR01 mortgage mortgage create with deed with charge number charge creation date
2022-10-26 NEWINC incorporation incorporation company

Credit score

Altman Z″ (private-firm) · reference 2025-03-31

-10.49

DISTRESS

Altman Z″

  • Working capital / Total assets -1.297 × 6.56 = -8.51
  • Retained earnings / Total assets 0.000 × 3.26 = +0.00
  • EBIT / Total assets -0.214 × 6.72 = -1.43
  • Book equity / Total liabilities -0.524 × 1.05 = -0.55

Bands: > 2.6 safe · 1.1–2.6 grey · < 1.1 distress. Z″ is a public-formula baseline, not a substitute for adverse-data signals (CCJs, charges, gazette notices) — those land in a later pass.

Activity Score

Composite activity score · components 0–100 · reference 2026-05-10

14.3

COLD

/ 100

  • Filings velocity 17
  • Capital events 0
  • Officer churn 0
  • Headcount trajectory 28
  • Accounts trajectory 39
  • 2 filing(s) in last 12 months
  • Employees -22% YoY
  • Turnover -11% YoY

Official Companies House page